These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

834 related articles for article (PubMed ID: 12729424)

  • 21. Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants.
    Marr KA; Crippa F; Leisenring W; Hoyle M; Boeckh M; Balajee SA; Nichols WG; Musher B; Corey L
    Blood; 2004 Feb; 103(4):1527-33. PubMed ID: 14525770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of new antifungal agents in prophylaxis of mycoses in high risk patients.
    van Burik JA
    Curr Opin Infect Dis; 2005 Dec; 18(6):479-83. PubMed ID: 16258319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease.
    Krishna G; Martinho M; Chandrasekar P; Ullmann AJ; Patino H
    Pharmacotherapy; 2007 Dec; 27(12):1627-36. PubMed ID: 18041883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
    Koh LP; Kurup A; Goh YT; Fook-Chong SM; Tan PH
    Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
    Glasmacher A; Cornely O; Ullmann AJ; Wedding U; Bodenstein H; Wandt H; Boewer C; Pasold R; Wolf HH; Hänel M; Dölken G; Junghanss C; Andreesen R; Bertz H;
    J Antimicrob Chemother; 2006 Feb; 57(2):317-25. PubMed ID: 16339606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tolerability and outcome of once weekly liposomal amphotericin B for the prevention of invasive fungal infections in hematopoietic stem cell transplant patients with graft-versus-host disease.
    Luu Tran H; Mahmoudjafari Z; Rockey M; Henry D; Grauer D; Aljitawi O; Abhyankar S; Ganguly S; Lin T; McGuirk J
    J Oncol Pharm Pract; 2016 Apr; 22(2):228-34. PubMed ID: 25471252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B.
    Harousseau JL; Dekker AW; Stamatoullas-Bastard A; Fassas A; Linkesch W; Gouveia J; De Bock R; Rovira M; Seifert WF; Joosen H; Peeters M; De Beule K
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1887-93. PubMed ID: 10858349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cost benefit analysis for prophylactic use of itraconazole versus fluconazole after hematopoietic stem cell transplantation].
    Ota S; Wada A; Kosugi M; Matsuoka S; Asanuma S; Fujii S; Noguchi S; Nakata M; Imai K; Hirano T; Kobayashi N; Ogasawara M; Kiyama Y; Kasai M
    Rinsho Ketsueki; 2010 Jan; 51(1):63-8. PubMed ID: 20134142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
    Glasmacher A; Prentice AG
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i23-i32. PubMed ID: 16120631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antifungal prophylaxis in allogenic hematopoietic stem-cell transplant recipients].
    Kanakura Y; Winston DJ
    Jpn J Antibiot; 2004 Aug; 57(4):421-4. PubMed ID: 15535043
    [No Abstract]   [Full Text] [Related]  

  • 31. Intravenous and oral sequential itraconazole antifungal prophylaxis in paediatric stem cell transplantation recipients: a pilot study for evaluation of safety and efficacy.
    Grigull L; Kuehlke O; Beilken A; Sander A; Linderkamp C; Schmid H; Seidemann K; Sykora KW; Schuster FR; Welte K
    Pediatr Transplant; 2007 May; 11(3):261-6. PubMed ID: 17430480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multicenter, randomized, open-label study comparing the efficacy and safety of micafungin versus itraconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplant.
    Huang X; Chen H; Han M; Zou P; Wu D; Lai Y; Huang H; Chen X; Liu T; Zhu H; Wang J; Hu J
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1509-16. PubMed ID: 22469884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients.
    Park S; Kim K; Jang JH; Kim SJ; Kim WS; Chung DR; Kang CI; Peck KR; Jung CW
    J Infect; 2016 Nov; 73(5):496-505. PubMed ID: 27394404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche dell' Adulto.
    Menichetti F; Del Favero A; Martino P; Bucaneve G; Micozzi A; Girmenia C; Barbabietola G; Pagańo L; Leoni P; Specchia G; Caiozzo A; Raimondi R; Mandelli F
    Clin Infect Dis; 1999 Feb; 28(2):250-5. PubMed ID: 10064240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group.
    Galgiani JN; Catanzaro A; Cloud GA; Johnson RH; Williams PL; Mirels LF; Nassar F; Lutz JE; Stevens DA; Sharkey PK; Singh VR; Larsen RA; Delgado KL; Flanigan C; Rinaldi MG
    Ann Intern Med; 2000 Nov; 133(9):676-86. PubMed ID: 11074900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antifungal prophylaxis with itraconazole oral solution in neutropenic patients.
    Kibbler CC
    Mycoses; 1999; 42 Suppl 2():121-4. PubMed ID: 10865918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials.
    Vardakas KZ; Michalopoulos A; Falagas ME
    Br J Haematol; 2005 Oct; 131(1):22-8. PubMed ID: 16173959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation.
    Wingard JR; Carter SL; Walsh TJ; Kurtzberg J; Small TN; Baden LR; Gersten ID; Mendizabal AM; Leather HL; Confer DL; Maziarz RT; Stadtmauer EA; Bolaños-Meade J; Brown J; Dipersio JF; Boeckh M; Marr KA;
    Blood; 2010 Dec; 116(24):5111-8. PubMed ID: 20826719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Itraconazole for secondary prophylaxis of invasive fungal infection in patients undergoing chemotherapy and stem cell transplantation].
    Shi JM; Wang C; Zhou YH; Yu K; Du X; Luo Y; Cai Z; He JS; Ye XJ; Zhang J; Xie WZ; Huang H
    Zhonghua Xue Ye Xue Za Zhi; 2013 May; 34(5):413-6. PubMed ID: 23688752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients.
    Bow EJ; Vanness DJ; Slavin M; Cordonnier C; Cornely OA; Marks DI; Pagliuca A; Solano C; Cragin L; Shaul AJ; Sorensen S; Chambers R; Kantecki M; Weinstein D; Schlamm H
    BMC Infect Dis; 2015 Mar; 15():128. PubMed ID: 25887385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.